$PDEX
PRO DEX INC Stock $pdex

$pdex Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000155335023000062 Filed on February 02, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue	$13.08M	$11.28M	$10.17M
YoY Change	41.17%	10.9%	23.01%
Cost Of Revenue	$9.268M	$8.659M	$6.769M
YoY Change	44.65%	27.92%	19.38%
Gross Profit	$3.811M	$2.623M	$3.404M
YoY Change	33.34%	-22.94%	30.92%
Gross Profit Margin	29.14%	23.25%	33.46%
Selling, General & Admin	$1.033M	$1.019M	$1.187M
YoY Change	-11.33%	-14.15%	8.9%
% of Gross Profit	27.11%	38.85%	34.87%
Research & Development	$713.0K	$467.0K	$615.0K
YoY Change	8.36%	-24.07%	-37.88%
% of Gross Profit	18.71%	17.8%	18.07%
Depreciation & Amortization	$210.0K	$191.0K	$182.0K
YoY Change	16.67%	4.95%	7.06%
% of Gross Profit	5.51%	7.28%	5.35%
Operating Expenses	$1.746M	$1.486M	$1.802M
YoY Change	-4.95%	-17.54%	-12.95%
Operating Profit	$2.065M	$1.137M	$1.602M
YoY Change	102.25%	-29.03%	202.26%
Interest Expense	$131.0K	$128.0K	-$392.0K
YoY Change	-133.85%	-132.65%	553.33%
% of Operating Profit	6.34%	11.26%	-24.47%
Other Income/Expense, Net	$122.0K	$2.619M	-$176.0K
YoY Change	-152.59%	-1588.07%	-112.49%
Pretax Income	$1.768M	$1.174M	$1.210M
YoY Change	178.86%	-2.98%	157.45%
Income Tax	$455.0K	$295.0K	$285.0K
% Of Pretax Income	25.74%	25.13%	23.55%
Net Earnings	$1.313M	$879.0K	$925.0K
YoY Change	184.2%	-4.97%	172.06%
Net Earnings / Revenue	10.04%	7.79%	9.09%
Basic Earnings Per Share	$0.37	$0.25	$0.25
Diluted Earnings Per Share	$0.36	$0.24	$245.6K
COMMON SHARES
Basic Shares Outstanding	3.544M shares	3.580M shares	3.657K shares
Diluted Shares Outstanding	3.623M shares	3.652K shares	3.767K shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.771M	$3.242M	$6.493M
YoY Change	-19.0%	-50.07%	-22.79%
Cash & Equivalents	$2.088M	$382.0K	$5.252M
Short-Term Investments	$2.683M	$2.860M	$1.241M
Other Short-Term Assets	$1.919M	$1.664M	$1.460M
YoY Change	15.39%	13.97%	175.47%
Inventory	$15.15M	$15.14M	$9.285M
Prepaid Expenses
Receivables	$10.57M	$12.20M	$8.850M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$31.15M	$31.39M	$26.09M
YoY Change	10.84%	20.31%	14.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.162M	$5.203M	$13.42M
YoY Change	-61.3%	-61.24%	12.15%
Goodwill
YoY Change
Intangibles	$87.00K	$98.00K
YoY Change
Long-Term Investments	$1.534M	$1.726M	$1.940M
YoY Change	-13.72%	-11.03%	-40.12%
Other Assets	$42.00K	$42.00K	$505.0K
YoY Change	-91.68%	-91.68%	68.33%
Total Long-Term Assets	$15.83M	$16.19M	$16.03M
YoY Change	0.29%	1.04%	2.34%
TOTAL ASSETS
Total Short-Term Assets	$31.15M	$31.39M	$26.09M
Total Long-Term Assets	$15.83M	$16.19M	$16.03M
Total Assets	$46.98M	$47.58M	$42.11M
YoY Change	7.04%	12.98%	9.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.068M	$3.364M	$2.315M
YoY Change	-13.16%	45.31%	-6.28%
Accrued Expenses	$2.425M	$3.314M	$1.812M
YoY Change	46.79%	82.89%	1.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.114M	$3.110M	$1.260M
YoY Change	89.65%	146.83%	162.5%
Total Short-Term Liabilities	$10.14M	$11.67M	$5.971M
YoY Change	31.35%	95.36%	21.12%
LONG-TERM LIABILITIES
Long-Term Debt	$9.247M	$9.590M	$10.90M
YoY Change	-12.56%	-12.01%	30.06%
Other Long-Term Liabilities	$1.745M	$1.850M	$3.239M
YoY Change	-47.36%	-42.88%	0.59%
Total Long-Term Liabilities	$10.99M	$11.44M	$14.14M
YoY Change	-20.86%	-19.08%	21.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.14M	$11.67M	$5.971M
Total Long-Term Liabilities	$10.99M	$11.44M	$14.14M
Total Liabilities	$21.14M	$23.11M	$20.11M
YoY Change	-2.21%	14.9%	21.65%
SHAREHOLDERS EQUITY
Retained Earnings	$19.25M	$17.94M	$15.34M
YoY Change	21.0%	16.97%	54.79%
Common Stock	$6.585M	$6.533M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$25.84M	$24.47M
YoY Change
Total Liabilities & Shareholders Equity	$46.98M	$47.58M	$42.11M
YoY Change	7.04%	12.98%	9.76%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	$1.313M	$879.0K	$925.0K
YoY Change	184.2%	-4.97%	172.06%
Depreciation, Depletion And Amortization	$210.0K	$191.0K	$182.0K
YoY Change	16.67%	4.95%	7.06%
Cash From Operating Activities	$2.338M	-$395.0K	$1.518M
YoY Change	997.65%	-126.02%	-23.33%
INVESTING ACTIVITIES
Capital Expenditures	$135.0K	$509.0K	-$224.0K
YoY Change	-168.18%	-327.23%	-96.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.000K	-$332.0K
YoY Change	-100.0%	-100.3%
Cash From Investing Activities	-$135.0K	-$508.0K	-$556.0K
YoY Change	-34.47%	-8.63%	-91.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-497.0K	-1.513M	-887.0K
YoY Change	-0.2%	70.57%	-117.46%
NET CHANGE
Cash From Operating Activities	2.338M	-395.0K	1.518M
Cash From Investing Activities	-135.0K	-508.0K	-556.0K
Cash From Financing Activities	-497.0K	-1.513M	-887.0K
Net Change In Cash	1.706M	-2.416M	75.00K
YoY Change	-447.45%	-3321.33%	-77.27%
FREE CASH FLOW
Cash From Operating Activities	$2.338M	-$395.0K	$1.518M
Capital Expenditures	$135.0K	$509.0K	-$224.0K
Free Cash Flow	$2.203M	-$904.0K	$1.742M
YoY Change	436.01%	-151.89%	-80.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
	dei	Entity Central Index Key EntityCentralIndexKey	0000788920
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	PRO DEX INC
CY2022Q4	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2021Q4	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity		usd
	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments		usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	pdex	Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
	pdex	Cashless Stock Option Exercise CashlessStockOptionExercise		usd
CY2021Q4	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-14942
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1261240
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2361 McGaw Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92614
	dei	City Area Code CityAreaCode	(949)
CY2022Q4	us-gaap	Assets Assets	47579000	usd
CY2022Q2	us-gaap	Assets Assets	47326000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3364000	usd
	dei	Local Phone Number LocalPhoneNumber	769-3200
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	PDEX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3543845	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	382000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	849000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	1134000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	755000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12195000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15384000	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	877000	usd
CY2022Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	710000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	15135000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	12678000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1664000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	790000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	31387000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	31166000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6296000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6343000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5203000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4833000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2063000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2248000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	98000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	118000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	764000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	797000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1726000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	1779000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3761000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2751000	usd
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue	6769000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	16791000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3314000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	13329000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	2623000	usd
CY2021Q4	us-gaap	Gross Profit GrossProfit	3404000	usd
CY2021Q4	us-gaap	Selling Expense SellingExpense	22000	usd
	us-gaap	Gross Profit GrossProfit	5578000	usd
	us-gaap	Selling Expense SellingExpense	122000	usd
	us-gaap	Selling Expense SellingExpense	59000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1026000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	544000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	851000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1013000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3110000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3285000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11665000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11354000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1850000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2054000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	9590000	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	10250000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11440000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12304000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	23105000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	23658000	usd
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3553929	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3553929	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3596131	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3596131	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	6533000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	7682000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17941000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15986000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24474000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23668000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47579000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47326000	usd
CY2022Q4	us-gaap	Revenues Revenues	11282000	usd
CY2021Q4	us-gaap	Revenues Revenues	10173000	usd
	us-gaap	Revenues Revenues	22369000	usd
	us-gaap	Revenues Revenues	20161000	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	8659000	usd
	us-gaap	Gross Profit GrossProfit	6832000	usd
CY2022Q4	us-gaap	Selling Expense SellingExpense	68000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1955000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1988000	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	951000	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1165000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1975000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2257000	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	467000	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	615000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1395000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1596000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	1486000	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	1802000	usd
	us-gaap	Operating Expenses OperatingExpenses	3492000	usd
	us-gaap	Operating Expenses OperatingExpenses	3912000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1137000	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1602000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2086000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2920000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	128000	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	117000	usd
	us-gaap	Interest Expense InterestExpense	258000	usd
	us-gaap	Interest Expense InterestExpense	237000	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	158000	usd
CY2021Q4	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-300000	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	408000	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-152000	usd
CY2022Q4	us-gaap	Interest And Fee Income Loans Other Consumer InterestAndFeeIncomeLoansOtherConsumer	7000	usd
CY2021Q4	us-gaap	Interest And Fee Income Loans Other Consumer InterestAndFeeIncomeLoansOtherConsumer	25000	usd
	us-gaap	Interest And Fee Income Loans Other Consumer InterestAndFeeIncomeLoansOtherConsumer	225000	usd
	us-gaap	Interest And Fee Income Loans Other Consumer InterestAndFeeIncomeLoansOtherConsumer	49000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	7000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1174000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1210000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2468000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2580000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	295000	usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	285000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	513000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	592000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	879000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	925000	usd
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2457000	usd
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3574	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3657	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3595	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3654	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3652	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3767	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3672	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3774	shares
CY2022Q4	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3554	shares
CY2021Q4	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3642	shares
	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3554	shares
	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3642	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23668000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	879000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	925000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1955000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1988000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24474000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	22005000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24474000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	22005000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1955000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1988000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	384000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	366000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	378000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	575000	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	408000	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-152000	usd
	pdex	Noncash Lease Expense NoncashLeaseExpense	1000	usd
	pdex	Noncash Lease Expense NoncashLeaseExpense	8000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-4000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-4000	usd
	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	7000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	46000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	33000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3187000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2081000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	167000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	231000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	848000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	874000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	577000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	147000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-376000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-162000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	434000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	481000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	595000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2497000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4219000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	334000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	687000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1072000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	89000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	24000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-598000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1430000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1349000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	672000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	45000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	30000	usd
	pdex	Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock	-223000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1800000	usd
	pdex	Principal Payments On Notes Payable And Revolving Loan PrincipalPaymentsOnNotesPayableAndRevolvingLoan	2639000	usd
	pdex	Principal Payments On Notes Payable And Revolving Loan PrincipalPaymentsOnNotesPayableAndRevolvingLoan	616000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2366000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1258000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-467000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1531000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	849000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3721000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5252000	usd
	us-gaap	Interest Paid Net InterestPaidNet	257000	usd
	us-gaap	Interest Paid Net InterestPaidNet	198000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	841000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	785000	usd
	pdex	Cashless Stock Option Exercise CashlessStockOptionExercise	45000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_ztViHaNIXat6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0">NOTE 2. <span id="xdx_827_z47QBZw4ZKZ5">DESCRIPTION OF BUSINESS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"><span id="a_DV_M441"/><span id="a_DV_M442"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">We specialize in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adaptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">In August 2020, we formed a wholly owned subsidiary, PDEX Franklin, LLC (“PDEX Franklin”), to hold title for an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”) that we acquired on November 6, 2020, in order to allow for the continued growth of our business. The condensed consolidated financial statements include the accounts of the Company and PDEX Franklin and all significant inter-company accounts and transactions have been eliminated. This subsidiary has no separate operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6500	shares
CY2022Q4	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-9000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	851000	usd
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	293000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.82
CY2022Q4	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	483000	usd
CY2021Q4	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	115000	usd
	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	1391000	usd
	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	311000	usd
CY2022Q4	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	10799000	usd
CY2021Q4	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	10058000	usd
	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	20978000	usd
	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	19850000	usd
CY2022Q4	us-gaap	Revenues Revenues	11282000	usd
CY2021Q4	us-gaap	Revenues Revenues	10173000	usd
	us-gaap	Revenues Revenues	22369000	usd
	us-gaap	Revenues Revenues	20161000	usd
CY2022Q4	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	312000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	862000	usd
CY2021Q4	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	98000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	98000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	851000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	591000	usd
CY2021Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	185000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	714000	usd
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	212000	usd
CY2022Q4	us-gaap	Accretion Expense AccretionExpense	412000	usd
CY2021Q4	us-gaap	Accretion Expense AccretionExpense	247000	usd
	us-gaap	Accretion Expense AccretionExpense	746000	usd
	us-gaap	Accretion Expense AccretionExpense	362000	usd
CY2022Q4	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-117000	usd
	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-566000	usd
	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-130000	usd
CY2021Q4	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-8000	usd
	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-17000	usd
	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-20000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	877000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	424000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	877000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	424000	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	25000	shares
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1013000	usd
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	150000	usd
CY2022Q4	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	312000	usd
CY2021Q4	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	389000	usd
	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	700000	usd
	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	532000	usd
CY2022Q4	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-312000	usd
CY2021Q4	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-98000	usd
	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-862000	usd
	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-98000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	851000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	584000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	851000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	584000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	8667000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	6323000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2622000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3463000	usd
CY2022Q4	pdex	Inventory Sub Assemblies InventorySubAssemblies	1880000	usd
CY2022Q2	pdex	Inventory Sub Assemblies InventorySubAssemblies	2118000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1966000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	774000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	15135000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	12678000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	1134000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	755000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1726000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	1779000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	2860000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.80
CY2022Q2	us-gaap	Marketable Securities MarketableSecurities	2534000	usd
CY2022Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2714000	usd
CY2022Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2796000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	146000	usd
	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	243000	usd
	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	97000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	262000	usd
CY2022	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	369000	usd
CY2022	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	107000	usd
CY2022Q4	pdex	Investment In Common Stock Affiliated With Company Board Members InvestmentInCommonStockAffiliatedWithCompanyBoardMembers	1134000	usd
CY2022Q2	pdex	Investment In Common Stock Affiliated With Company Board Members InvestmentInCommonStockAffiliatedWithCompanyBoardMembers	755000	usd
CY2022Q4	us-gaap	Land Land	3684000	usd
CY2022Q2	us-gaap	Land Land	3684000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	2815000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	2815000	usd
CY2022Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	6499000	usd
CY2022Q2	us-gaap	Land And Land Improvements LandAndLandImprovements	6499000	usd
CY2022Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	203000	usd
CY2022Q2	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	156000	usd
CY2022Q4	pdex	Land And Building Net LandAndBuildingNet	6296000	usd
CY2022Q2	pdex	Land And Building Net LandAndBuildingNet	6343000	usd
CY2020Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6500000	usd
CY2020Q4	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1300000	usd
CY2020Q4	pdex	Bank Financed BankFinanced	5200000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P30Y
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-110000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-90000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	118000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	21000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	42000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	255000	usd
CY2022Q4	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3574	shares
CY2021Q4	us-gaap	Acquisition Costs AcquisitionCosts	46000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	344000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	340000	usd
CY2022Q4	us-gaap	Product Warranty Expense ProductWarrantyExpense	56000	usd
CY2021Q4	us-gaap	Product Warranty Expense ProductWarrantyExpense	44000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	123000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	68000	usd
CY2022Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	365000	usd
CY2021Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	232000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	340000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	221000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	55000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	33000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	109000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	64000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	1000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	11000	usd
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	14000	usd
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	4000	usd
CY2022Q4	pdex	Product Warranty Accrual Amortization And Utilization ProductWarrantyAccrualAmortizationAndUtilization	-77000	usd
CY2021Q4	pdex	Product Warranty Accrual Amortization And Utilization ProductWarrantyAccrualAmortizationAndUtilization	-21000	usd
	pdex	Product Warranty Accrual Amortization And Utilization ProductWarrantyAccrualAmortizationAndUtilization	-119000	usd
	pdex	Product Warranty Accrual Amortization And Utilization ProductWarrantyAccrualAmortizationAndUtilization	-34000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	344000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	344000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	255000	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	879000	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	925000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1955000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1988000	usd
CY2021Q4	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3657	shares
	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3595	shares
	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3654	shares
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	879000	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	925000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1955000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1988000	usd
CY2022Q4	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3574	shares
CY2021Q4	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3657	shares
	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3595	shares
	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3654	shares
CY2022Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	78	shares
CY2021Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	110	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	77	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	120	shares
CY2022Q4	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3652	shares
CY2021Q4	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3767	shares
	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3672	shares
	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3774	shares
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	54000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	61000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6500	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.82
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31500	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.81
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.82
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	6500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.82
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y6M
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	321000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2247000	usd
	pdex	Major Customers Suppliers Description MajorCustomersSuppliersDescription	Amounts owed to the fiscal 2023 three most significant suppliers at December 31, 2022, totaled $1.5 million, $53,000 and $166,000, respectively, and at June 30, 2022, totaled $721,000, $430,000 and $372,000, respectively.
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	397000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0553	pure
CY2022Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	127000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	250000	usd
CY2021Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	123000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	243000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	254000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	519000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	535000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	551000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	567000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	142000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2568000	usd

Files In Submission

Name	View Source	Status
0001553350-23-000062-index-headers.html	Edgar Link	pending
0001553350-23-000062-index.html	Edgar Link	pending
0001553350-23-000062.txt	Edgar Link	pending
0001553350-23-000062-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pdex-20221231.xsd	Edgar Link	pending
pdex_10q.htm	Edgar Link	pending
pdex-20221231_cal.xml	Edgar Link	unprocessable
pdex-20221231_def.xml	Edgar Link	unprocessable
pdex-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
pdex_10q_htm.xml	Edgar Link	completed
pdex-20221231_pre.xml	Edgar Link	unprocessable
pdex_ex31z1.htm	Edgar Link	pending
pdex_ex31z2.htm	Edgar Link	pending
pdex_ex32z1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PDEX
PRO DEX INC Stock $pdex

2023 Q1 Form 10-Q Financial Statement

#000155335023000062 Filed on February 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX PRO DEX INC Stock $pdex

2023 Q1 Form 10-Q Financial Statement

#000155335023000062 Filed on February 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX
PRO DEX INC Stock $pdex